Skip to main content

Table 3 Cohort analysis: adjusted associations of height quintiles with NAFLD a in females

From: Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome

Cox proportional-hazard regression models

Quintiles of body height (cm, range)

p for trend b

Level 1 (138.0–156.2)

Level 2 (156.3–159.5)

Level 3 (159.6–162.1)

Level 4 (162.2–165.4)

Level 5 (165.5–184.6)

(n = 4223)

(n = 4442)

(n = 3947)

(n = 4145)

(n = 4370)

Person-years of follow-up

11,318

12,593

11,153

11,576

12,736

 

No. of NAFLD

548

543

454

416

404

 

 Model 1 d

1.00

0.88 (0.78, 0.99) c

0.83 (0.73, 0.94)

0.73 (0.64, 0.83)

0.64 (0.57, 0.73)

< 0.0001

 Model 2 e

1.00

0.91 (0.81, 1.02)

0.85 (0.75, 0.96)

0.75 (0.66, 0.85)

0.62 (0.55, 0.71)

< 0.0001

 Model 3 f

1.00

0.92 (0.82, 1.04)

0.85 (0.75, 0.97)

0.78 (0.68, 0.89)

0.65 (0.57, 0.74)

< 0.0001

 Model 4 g

1.00

0.97 (0.86, 1.09)

0.98 (0.86, 1.11)

0.93 (0.81, 1.06)

0.84 (0.73, 0.96)

0.02

 Model 5 h

1.00

0.80 (0.69, 0.91)

0.72 (0.61, 0.85)

0.60 (0.49, 0.74)

0.45 (0.35, 0.59)

< 0.0001

  1. aNAFLD, non-alcoholic fatty liver disease
  2. bAnalysis by Cox proportional hazards model
  3. cAdjusted hazard ratios (95% confidence interval) (all such values)
  4. dCrude
  5. eAdjusted for age and waist circumference
  6. fAdjusted for age, waist circumference, smoking status, drinking status, metabolic syndrome, and family history of cardiovascular disease, hypertension, hyperlipidemia, and diabetes
  7. gAdjusted for age, body mass index, waist circumference, smoking status, drinking status, metabolic syndrome, and family history of cardiovascular disease, hypertension, hyperlipidemia, and diabetes
  8. hAdjusted for age, body mass index, waist-to-height ratio, waist circumference, smoking status, drinking status, metabolic syndrome, and family history of cardiovascular disease, hypertension, hyperlipidemia, and diabetes